Acelrx Pharmaceuticals reported $1.04M in Cost of Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acelrx Pharmaceuticals ACRX:US $ 1.04M 0M
Baxter International BAX:US $ 1856M 75M
Becton, Dickinson and BDX:US $ 2729M 68M
Biodelivery Sciences International BDSI:US $ 4.28M 1.54M
Heron Therapeutics HRTX:US $ 14.52M 5.32M
Intra Cellular Therapies ITCI:US $ 2.04M 0.58M
Johnson & Johnson JNJ:US $ 7587M 551M
Pfizer PFE:US $ 6992M 2820M
Smiths SMIN:LN 782M 73M
Teva Pharmaceutical TEVA:IT 1.99B 76M
Xeris Pharmaceuticals Inc XERS:US $ 3.38M 1.56M
Zogenix ZGNX:US $ 1.22M 0.55M